Publications


Results 1-61 of 61 (Search time: 0.02 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12023Cone-Beam Computed-Tomography-Derived Augmented Fluoroscopy-Guided Biopsy for Peripheral Pulmonary Nodules in a Hybrid Operating Room: A Case SeriesLUN-CHE CHEN ; Yang, Shun-Mao; Malwade, Shwetambara; Chang, Hao-Chun; Chang, Ling-Kai; Chung, Wen-Yuan; JEN-CHUNG KO ; CHONG-JEN YU Diagnostics (Basel, Switzerland)00
22023Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature ReviewCHIA-HAO CHANG ; LIH-YU CHANG ; JEN-CHUNG KO ; Wen, Yueh-Feng; CHIEN-JEN CHANG ; LI-TA KENG ; PING-HSIEN TSOU ; KAI-LUN YU ; JANN-YUAN WANG ; CHONG-JEN YU Infectious diseases and therapy00
32022Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cellsJEN-CHUNG KO ; Chen, Jyh-Cheng; Hsieh, Jou-Min; Tseng, Pei-Yu; Chiang, Chen-Shan; Liu, Li-Ling; Chien, Chin-Cheng; Huang, I-Hsiang; Chang, Qiao-Zhen; Mu, Bo-Cheng; Lin, Yun-WeiBiochemical pharmacology11
42022Capsaicin Acts Through Reducing P38 MAPK-Dependent Thymidylate Synthase Expression to Enhance 5-Fluorouracil-Induced Cytotoxicity in Human Lung Cancer CellsTung C.-L.; Chen J.-C.; JEN-CHANG KO ; Liu L.-L.; Chien C.-C.; Huang I.-H.; Tsao Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.Natural Product Communications22
52022Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cellsJEN-CHUNG KO Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells11
62021Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesionsKAI-LUN YU ; SHUN-MAO YANG ; Ko, Huan-Jang; Tsai, Hui-Yu; JEN-CHUNG KO ; CHING-KAI LIN ; CHAO-CHI HO ; JIN-YUAN SHIH Respiration87
72021Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer CellsChen J.-C.; JEN-CHANG KO ; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.Pharmacology23
82021Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous CellsJEN-CHUNG KO Pharmacology00
92021Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry CohortSHENG-KAI LIANG ; LI-TA KENG ; Chang, Chia-Hao; Wen, Yueh-Feng; MENG-RUI LEE ; CHING-YAO YANG ; JANN-YUAN WANG ; JEN-CHUNG KO ; JIN-YUAN SHIH ; CHONG-JEN YU Frontiers in Oncology12
102021Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer disseminationKuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHUNG KO ; Chou Y.-T.Cancer Research1919
112021Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical VentilationLI-TA KENG ; SHENG-KAI LIANG ; Tseng C.-P.; Wen Y.-F.; PING-HSIEN TSOU ; Chang C.-H.; LIH-YU CHANG ; KAI-LUN YU ; MENG-RUI LEE ; JEN-CHUNG KO Frontiers in Medicine11
122021Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancerPING-HSIEN TSOU ; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; SHENG-KAI LIANG ; Wen Y.-F.; Chang C.-H.; LIH-YU CHANG ; KAI-LUN YU ; Liu C.-J.; LI-TA KENG ; MENG-RUI LEE ; JEN-CHUNG KO ; Huang G.-H.; Li Y.-K.Cancers1614
132020Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational studyMENG-RUI LEE ; Huang H.-L; LUN-CHE CHEN ; HUNG-CHIH YANG ; JEN-CHUNG KO ; Cheng M.-H; Chong I.-W; LI-NA LEE ; JANN-YUAN WANG ; Dimopoulos G.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases1618
142020Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIsChang C.H. ; Lee C.-H.; JEN-CHUNG KO ; LIH-YU CHANG ; Lee M.-C.; Zhang J.-F.; JANN-YUAN WANG ; JIN-YUAN SHIH ; CHONG-JEN YU Frontiers in Oncology56
152020Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer CellsJEN-CHANG KO ; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.Pharmacology24
162020Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort studyMENG-RUI LEE ; Lee C.-H.; JANN-YUAN WANG ; Lee S.-W.; JEN-CHANG KO ; LI-NA LEE Journal of the Formosan Medical Association34
172020Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic reviewMENG-RUI LEE ; LIH-YU CHANG ; JEN-CHANG KO ; HAO-CHIEN WANG ; Huang Y.-W.Journal of the Formosan Medical Association86
182019Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutationsSHENG-KAI LIANG ; JEN-CHUNG KO ; CHIH-HSIN YANG ; JIN-YUAN SHIH Lung Cancer2221
192019Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cellsChen J.-C.; JEN-CHANG KO ; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.Toxicology Research129
202019Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE studyWei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHUNG KO ; Lin C.-M.; Hsia T.-C.Journal of Cancer55
212019Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort studyMENG-RUI LEE ; KAI-LUN YU ; HUNG-YANG KUO ; TSUNG-HAO LIU ; JEN-CHUNG KO ; JAW-SHIUN TSAI ; JANN-YUAN WANG Scientific Reports1210
222019Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cellsJEN-CHUNG KO ; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.Toxicology33
232018Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort studySHENG-KAI LIANG ; MENG-RUI LEE ; WEI-YU LIAO ; CHAO-CHI HO ; JEN-CHUNG KO ; JIN-YUAN SHIH Oncotarget160
242018Psychological distress and coping strategies among women with incurable lung cancer: a qualitative studyLiao Y.-C.; WEI-YU LIAO ; Sun J.-L.; JEN-CHANG KO ; CHONG-JEN YU Supportive Care in Cancer1818
252017Cementing an unwanted relationshipChang C.-H.; LI-TA KENG ; JEN-CHUNG KO Thorax00
262017Tuberculosis contact investigation in an intermediate burden setting: Implications from a large tuberculosis contact cohort in TaiwanMENG-RUI LEE ; CHENG-MAW HO ; Lee C.-H.; Lee M.-C.; LIH-YU CHANG ; KAI-LUN YU ; JEN-CHUNG KO ; JANN-YUAN WANG ; JANN-TAY WANG ; LI-NA LEE European Respiratory Journal1414
272017Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinomaSHENG-KAI LIANG ; MIN-SHU HSIEH ; MENG-RUI LEE ; LI-TA KENG ; JEN-CHUNG KO ; JIN-YUAN SHIH Oncotarget5551
282017Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and MetaanalysisMENG-RUI LEE ; YA-PING HUANG ; Kuo, Yu-Ting; Luo, Chen-Hao; Shih, Yun-Ju; CHIN-CHUNG SHU ; JANN-YUAN WANG ; JEN-CHANG KO ; CHONG-JEN YU ; HSIEN-HO LIN Clinical infectious diseases : an official publication of the Infectious Diseases Society of America7780
292017Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in TaiwanLIH-YU CHANG ; Lee C.-H.; JEN-CHANG KO ; Chang L.-Y.; Lee M.-C.; JANN-YUAN WANG ; CHONG-JEN YU Cancer Medicine87
302016Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cellsPan, Chun-Hao; Chang, Ying-Fang; Lee, Ming-Shuo; Wen, B-Chen; JEN-CHUNG KO ; SHENG-KAI LIANG ; Liang, Mei-ChihBMC cancer3126
312016Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilitiesMENG-RUI LEE ; Tsai C.-J.; Hu J.-Y.; Lee S.-W.; JEN-CHUNG KO ; HAO-CHIEN WANG ; CHONG-JEN YU ; LI-NA LEE ; PO-REN HSUEH Future Microbiology66
322016Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cellsJEN-CHANG KO ; Chen J.-C.; Wang T.-J.; Zheng H.-Y.; Chen W.-C.; Chang P.-Y.; Lin Y.-W.Biochemical Pharmacology4443
332016Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expressionJEN-CHUNG KO ; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.Biochemical Pharmacology88
342015Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cellsJEN-CHANG KO ; Chiu H.-C.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Jian Y.-J.; Chang P.-Y.; Wang T.-J.; Lin Y.-W.Biochemical and Biophysical Research Communications88
352015Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer CellsJEN-CHANG KO ; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.Basic and Clinical Pharmacology and Toxicology2015
362015Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cellsJEN-CHANG KO ; Wang T.-J.; Chang P.-Y.; Syu J.-J.; Chen J.-C.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Zheng H.-Y.; Chen W.-C.; Lin Y.-W.Biochemical Pharmacology44
372015Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examinationMENG-RUI LEE ; Yang C.-Y.; CHIN-CHUNG SHU ; CHING-KAI LIN ; Wen Y.-F.; Lee S.-W.; JEN-CHUNG KO ; JANN-YUAN WANG ; LI-NA LEE ; CHONG-JEN YU Clinical Microbiology and Infection2018
382014Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012MENG-RUI LEE ; HAO-CHIEN WANG ; CHING-YAO YANG ; CHING-KAI LIN ; HAN-YUEH KUO ; JEN-CHUNG KO ; WANG-HUEI SHENG ; LI-NA LEE ; CHONG-JEN YU ; PO-REN HSUEH European Journal of Clinical Microbiology and Infectious Diseases98
392014Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolatesMENG-RUI LEE ; JEN-CHUNG KO ; SHENG-KAI LIANG ; Lee S.-W.; Yen D.H.-T.; PO-REN HSUEH International Journal of Antimicrobial Agents1313
402014Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cellsJEN-CHANG KO ; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W.Biochemical Pharmacology2625
412013Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cellsChen R.-S.; JEN-CHANG KO ; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Chen H.-J.; Huang Y.-C.; Jian Y.-J.; Lee W.-T.; Lin Y.-W.Naunyn-Schmiedeberg's Archives of Pharmacology88
422013Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cellsJEN-CHANG KO ; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Huang Y.-C.; Chen H.-J.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.Lung Cancer2019
432013Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cellsJEN-CHANG KO ; Huang Y.-C.; Chen H.-J.; Tseng S.-C.; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Weng S.-H.; Chiou R.Y.Y.; Lin Y.-W.Basic and Clinical Pharmacology and Toxicology1716
442012HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cellsJEN-CHANG KO ; Chen H.-J.; Huang Y.-C.; Tseng S.-C.; Weng S.-H.; Wo T.-Y.; Huang Y.-J.; Chiu H.-C.; Tsai M.-S.; Chiou R.Y.Y.; Lin Y.-W.Regulatory Toxicology and Pharmacology1718
452011Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabineJEN-CHUNG KO ; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W.Biochemical Pharmacology2724
462011Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cellsJEN-CHUNG KO ; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W.Toxicology and Applied Pharmacology3633
472011Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cellsJEN-CHUNG KO ; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W.Journal of Pharmacology and Experimental Therapeutics1819
482010Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.Lung Cancer4741
492010Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cellsJEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.Biochemical Pharmacology6860
502009Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cellsJEN-CHUNG KO ; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.Molecular Cancer Research4440
512009The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cellsJEN-CHUNG KO ; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.Lung Cancer99
522009Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivationChen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHUNG KO ; Lin Y.-W.Experimental Cell Research2725
532008Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cellsJEN-CHUNG KO ; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.Molecular Cancer Therapeutics3734
542008Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cellsJEN-CHUNG KO ; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.Carcinogenesis5554
552008The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancerJEN-CHUNG KO ; Hong J.-H.; Wang L.-H.; Lin Y.-W.Experimental Cell Research1414
562005Disseminated coccidioidomycosis [8]Wang C.-Y.; JIH-SHUIN JERNG ; JEN-CHUNG KO ; Lin M.-F.; Hsiao C.-H.; LI-NA LEE ; PO-REN HSUEH ; Kuo S.-H.Emerging Infectious Diseases1512
572004Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxiaJEN-CHUNG KO ; Wang Y.-T.; Yang J.-L.Experimental Cell Research1714
581994Superior vena cava syndrome: Rapid histologic diagnosis by ultrasound-guided transthoracic needle aspiration biopsyJEN-CHUNG KO ; PAN-CHYR YANG ; ANG YUAN ; Chang D.-B.; CHONG-JEN YU ; HUEY-DONG WU ; LI-NA LEE ; Kuo S.-H.; KWEN-TAY LUH American Journal of Respiratory and Critical Care Medicine2011
591994Ultrasonographic evaluation of peridiaphragmatic lesions: A prospective studyJEN-CHANG KO ; PAN-CHYR YANG ; Chang D.-B.; CHONG-JEN YU ; LI-NA LEE ; Kuo S.-H.; KWEN-TAY LUH Journal of Medical Ultrasound6
601994Panhypopituitarism caused by solitary parasellar metastasis from lung cancerJEN-CHANG KO ; PAN-CHYR YANG ; TIEN-SHANG HUANG ; KUN-HUEI YEH ; Kuo S.-H.; KWEN-TAY LUH Chest1917
611992Lobar bronchioloalveolar carcinoma: an ultrasound study.JEN-CHUNG KO ; PAN-CHYR YANG ; KWEN-TAY LUH ; Kuo S.H.; Chang D.B.; CHONG-JEN YU Journal of the Formosan Medical Association = Taiwan yi zhi30